The surface tension of alveolar fluid is regulated by pulmonary surfactant, allowing efficient respiration.
- Describe surfactant and its role in alveolar fluid surface tension
- Type II avleolar epithelial cells secrete pulmonary surfactant to lower the surface tension of water, which helps prevent airway collapse.
- Reinflation of the alveoli following exhalation is made easier by pulmonary surfactant.
- The surfactant reduces surface tension within all alveoli through hydrophilic and hydrophobic forces.
- Insufficient pulmonary surfactant in the alveoli can contribute to atelectasis (collapse of part or all of the lung ).
- Premature infants often don’t have the capacity to produce enough surfactant to survive on their own.
- atelectasis: The collapse of a part of or the whole lung caused by inner factors, rather than a pneumothorax.
- surfactant: A lipoprotein in the tissues of the lung that reduces surface tension and permits more efficient gas transport.
- Surface tension: The inward force created by films of molecules that can reduce the area of a surface.
Elective cesarean sections are becoming more common. One unfortunate consequence of this is that many of the infants delivered by this method are actually slightly physiologically premature. They lack sufficient surfactant to initiate proper breathing, and therefore, go into respiratory distress.
The alveoli are highly elastic structures in the parenchyma of the lungs that are the functional site of gas exchange. As the alveoli fill with air during inhalation they expand, and as air leaves the lung with exhalation, the alvoli return to their non-inflated size. The reason for the elasticity of the alveoli is a protein found in the extracellular matrix of the alveoli, called elastin, as well as the surface tension of water molecules on the alveoli themselves.
Surface Tension in the Lung
Surface tension is the force exerted by water molecules on the surface of the lung tissue as those water molecules pull together. Water (H2O) is a highly polar molecule, so it forms strong covalent bonds with other water molecules. The force of these covalent bonds effectively creates an inward force on surfaces, such as lung tissue, with the effect of lowering the surface area of that surface as the tissue is pulled together. As the air inside the lungs is moist, there is considerable surface tension within the tissue of the lungs. Because the alveoli of the lungs are highly elastic, they do not resist surface tension on their own, which allows the force of that surface tension to deflate the alveoli as air is forced out during exhalation by the contraction of the pleural cavity.
The force of surface tension in the lungs is so great that without something to reduce the surface tension, the airways would collapse after exhalation, making re-inflation during inhalation much more difficult and less effective. Collapse of the lungs is called alectasis. Fortunately, the type II epithelial cells of the alveoli continually secrete a molecule called surfactant that solves this problem.
Surfactant is a lipoprotein molecule that reduces the force of surface tension from water molecules on the lung tissue. The main reason that surfactant has this function is due to a lipid called dipalmitoylphosphatidylcholine (DPPC) which contains hydophilic and hydrophobic ends. The hydrophilic ends are water soluable and attach to the water molecules on the surface of the lungs. The hydrophilic ends are water insoluable and face towards the air and pull away from the water. The net result is that the surface tension of the lungs from water is reduced so that the lungs can still inflate and deflate properly without the possibility of collapse from surface tension alone.
As unborn humans grow and develop in the womb, they receive oxygen from the mother, so their lungs aren’t fully functional right away. Of particular importance is the fact that they don’t produce surfactant until 24 weeks of development and usually don’t have enough built up to prevent lung collapse until 35 weeks of development. Therefore prematurely born infants are at a high risk of respiratory distress syndrome from airway collapse, which can cause death if untreated. It is treated through pulmonary surfactant replacement therapy and mechanical ventilator treatment until the infant’s lungs are old enough to secrete enough surfactant to survive on their own. Other diseases may cause atelectasis, such as COPD, or any sort of lung trauma and inflammation that involves extensive damage to the pleural cavity or the lung parenchyma.
Diagram of an Alveoli: An alveoli with both cross-section and external views